Key result
Percutaneous LVAD unloads ventricular pressure across pump speeds but worsens flow pulsatility, shear stress, and hemolysis.
Why the study?
Does varying percutaneous left ventricular assist device (PLVAD) pump speed affect ventricular hemodynamics and hemocompatibility in a computational model of the left ventricle?
Does varying percutaneous left ventricular assist device (PLVAD) pump speed affect ventricular hemodynamics and hemocompatibility in a computational model of the left ventricle?
Answers are grounded in this paper and cite their sources.
Computational fluid dynamics modeling demonstrates a critical trade-off in PLVAD therapy where higher pump speeds improve ventricular unloading but exacerbate shear stress, platelet activation, and hemolysis risk.
Percutaneous left ventricular assist devices (PLVADs) provide cardiac support in heart failure, yet the hemodynamic effects of varying support levels and the balance between ventricular unloading and blood trauma remain unclear. This study employed numerical simulations to analyze a PLVAD-supported left ventricle under three pump speeds: low, high, and normal control. Analysis encompassed both conventional hemodynamic parameters (e.g., TAWSS, OSI, RRT) and validated mathematical model. Results showed that PLVAD support enlarged the vortex core and increased vorticity in the left ventricle, while reducing them at the aortic outlet. It effectively lowered ventricular wall pressure—achieving unloading—but also decreased aortic outlet WSS. Furthermore, PLVAD elevated OSI and ECAP while reducing TAWSS and RRT, effects that intensified at higher speeds. Increased speed also raised non-physiological scalar shear stress (SSS) and platelet activation, significantly increasing the hemolysis index in the rotational domain and elevating blood damage risk in the ventricular chamber compared to normal physiology. In conclusion, while PLVAD effectively unloads the ventricle, it impairs flow pulsatility and hemocompatibility. Controlling high-speed-induced SSS and platelet activation is critical to mitigate hemolysis. Monitoring hemocompatibility indicators—especially in the apical and aortic outlet regions—is essential due to their link with thrombosis and adverse events. Export citation and abstract BibTeX RIS
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied Heart failure. Percutaneous left ventricular assist device (PLVAD) support at low and high pump speeds vs. Normal control was evaluated on Ventricular hemodynamics (TAWSS, OSI, RRT, ECAP, wall pressure) and hemocompatibility (scalar shear stress, platelet activation, hemolysis index). Percutaneous LVAD support unloaded ventricular wall pressure across 3 simulated pump speeds, but impaired flow pulsatility and increased scalar shear stress, platelet activation, and hemolysis.
Synapse has enriched 10 related papers. Consider them for comparative context: